"Repurposing starts with the human genome," a precision medicine expert said in explaining Vanderbilt's new approach to accelerating clinical trials.
The newly emerged Nashville Biosciences has the considerable genomics and bioinformatics resources of Vanderbilt behind it as it promotes new R&D techniques.
The researchers developed phenotype risk scores that they could apply to electronic health record data to uncover undiagnosed genetic disease.
Tempus will use its recently launched Tempus O informatics platform to collect and structure clinical data from VICC's electronic health records.
The Vanderbilt Center for Undiagnosed Diseases will use FDNA's Face2Gene to help evaluate difficult-to-diagnose patients.
The Universal Influenza Vaccine Initiative, led by Vanderbilt and the Human Vaccines Project, has turned to omics and AI to create more effective flu vaccines.
Living DNA and its partners are aiming to create a detailed genetic map of the world based on people's DNA.
The partners will integrate genomic analyses and de-identified clinical data into Goldfinch's genomic registry of kidney disease patients.
Bioinformatics and genomic medicine stand to have outsize influence in the the new, university-wide Vanderbilt Data Science Visions Working Group.
The head of the data center for the Precision Medicine Initiative's All of Us program discusses plans to manage records on 1 million people from dozens of sites.
A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.
Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.
In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.
A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.